Stock Events

Stock Events

Acrivon Therapeutics (ACRV) Q1 2025 Earnings

27MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.84

-0.73

-0.63

-0.52

Details

Expected EPS

-0.663644

Actual EPS

-0.6

Surprise EPS

0.06

Surprise Percent

+9.59%

Description

Acrivon Therapeutics (ACRV) has reported earnings of -0.6 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.